✦ LIBER ✦

1144 A phase 2 clinical study evaluating safety and efficacy of Hepex-B, a mixture of two human monoclonal antibodies to HBsAg in combination with lamivudine in chronic HBV patients

✍ Scribed by GALUN, E; SAFADI, R; MILCHEM, A; AKERMAN, Z; ASHUR, Y; MATHOT, I; YOUNOSSI, Z; MINUK, G; NUSSBAUM, O; TERKIELTAUB, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1181 A phase III, partially double-blind

✍ MARCELLIN, P; LAU, G; BONINO, F; FARCI, P; HADZIYANNIS, S; JIN, R; LU, Z; PIRATV 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

A phase II, randomized, double-blind, pl

✍ Michael Yellin; Igor Paliienko; Andra Balanescu; Semen Ter-Vartanian; Vira Tselu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Phase 1b study of safety, tolerability a

✍ Mahadevan, Daruka; Sutton, Gregory Ryan; Arteta-Bulos, Rafael; Bowden, Chris J.; 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 747 KB

Efficacy, safety, and tolerability of a

✍ Robert P Giugliano; Nihar R Desai; Payal Kohli; William J Rogers; Ransi Somaratn 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 353 KB

Safety, Tolerability, Pharmacokinetics a

✍ Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 157 KB

3LBA SOLTI-0701: A double-blind, randomi

✍ J. Baselga; J.G.M. Segalla; H. Roché; A. del Giglio; E.M. Ciruelos; S. Cabral Fi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB